Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Tiphaine Raia-Barjat, Carole Prieux, Jean-Christophe Gris, Céline Chapelle, Silvy Laporte & Céline Chauleur. (2019) Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study. The Journal of Maternal-Fetal & Neonatal Medicine 32:2, pages 248-257.
Read now
Read now
Saira Salahuddin, Julia B. Wenger, Dongsheng Zhang, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2016) KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes. Hypertension in Pregnancy 35:3, pages 330-345.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Amy E. Whitten, Steven J. Korzeniewski, Piya Chaemsaithong, Edgar Hernandez-Andrade, Lami Yeo & Sonia S. Hassan. (2016) The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 29:8, pages 1214-1228.
Read now
Read now
Constance Leung, Rahmah Saaid, Lars Pedersen, Felicity Park, Leona Poon & Jon Hyett. (2015) Demographic factors that can be used to predict early-onset pre-eclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 28:5, pages 535-539.
Read now
Read now
Kedak Baltajian, Jonathan L. Hecht, Julia B. Wenger, Saira Salahuddin, Stefan Verlohren, Frank H. Perschel, Zsuzsanna K. Zsengeller, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2014) Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertension in Pregnancy 33:4, pages 427-439.
Read now
Read now
Kate E Duhig, Lucy C Chappell & Andrew H Shennan. (2014) How placental growth factor detection might improve diagnosis and management of pre-eclampsia. Expert Review of Molecular Diagnostics 14:4, pages 403-406.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Josef M. Cortez, Athina Pappas, Adi L. Tarca, Piya Chaemsaithong, Zhong Dong, Lami Yeo & Sonia S. Hassan. (2014) Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. The Journal of Maternal-Fetal & Neonatal Medicine 27:2, pages 132-144.
Read now
Read now
Nikolaos Vrachnis, Emmanouil Kalampokas, Stavros Sifakis, Nikolaos Vitoratos, Theodoros Kalampokas, Demetrios Botsis & Zoe Iliodromiti. (2013) Placental growth factor (PlGF): a key to optimizing fetal growth. The Journal of Maternal-Fetal & Neonatal Medicine 26:10, pages 995-1002.
Read now
Read now
Sarosh Rana, William T. Schnettler, Camille Powe, Julia Wenger, Saira Salahuddin, Ana Sofia Cerdeira, Stefan Verlohren, Frank H. Perschel, Zoltan Arany, Kee-Hak Lim, Ravi Thadhani & S. Ananth Karumanchi. (2013) Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertension in Pregnancy 32:2, pages 189-201.
Read now
Read now
Articles from other publishers (45)
Atakan Tanacan, Bedri Sakcak, Goksun Ipek, Zahid Agaoglu, Ayca Peker, Murat Haksever, Ozgur Kara & Dilek Sahin. (2023) The role of first trimester eosinophil count and eosinophil-based complete blood cell indices in the predictiction of preeclampsia: A case-control study. Placenta 143, pages 16-21.
Crossref
Crossref
A.V. Pylypenko & V.I. Medved. (2022) To the question of the clinical predictive value of the sFlt-1:PlGF ratio is related to the placental dysfunction. Reproductive health of woman:7, pages 21-29.
Crossref
Crossref
Ravi Thadhani, Elizabeth Lemoine, Sarosh Rana, Maged M. Costantine, Vinicius F. Calsavara, Kim Boggess, Blair J. Wylie, Tiffany A. Moore Simas, Judette M. Louis, Jimmy Espinoza, Stephanie L. Gaw, Amy Murtha, Samantha Wiegand, Yvonne Gollin, Deepjot Singh, Robert M. Silver, Danielle E. Durie, Britta Panda, Errol R. Norwitz, Irina Burd, Beth Plunkett, Rachel K. Scott, Anna Gaden, Martha Bautista, Yuchiao Chang, Marcio A. Diniz, S. Ananth Karumanchi & Sarah Kilpatrick. (2022) Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy. NEJM Evidence 1:12.
Crossref
Crossref
Anca-Florina Tataru-Copos, Mircea Ioachim Popescu, Romina Murvai & Amin El Kharoubi. (2022) Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis. Medicina 58:9, pages 1196.
Crossref
Crossref
Sarosh Rana, Suzanne D. Burke & S. Ananth Karumanchi. (2022) Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. American Journal of Obstetrics and Gynecology 226:2, pages S1019-S1034.
Crossref
Crossref
S. Ananth Karumanchi, Sarosh Rana & Robert N. Taylor. 2022. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
165
185
.
Shaikha Alabduljabbar, Sara Al Zaidan, Arun Prasath Lakshmanan & Annalisa Terranegra. (2021) Personalized Nutrition Approach in Pregnancy and Early Life to Tackle Childhood and Adult Non-Communicable Diseases. Life 11:6, pages 467.
Crossref
Crossref
Revathi Soundararajan, Sunitha C. Suresh, Ariel Mueller, Sarah Heimberger, Smitha Avula, Chaitra Sathyanarayana, Sunitha Mahesh, Sushma Madhuprakash & Sarosh Rana. (2021) Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study. Pregnancy Hypertension 23, pages 97-103.
Crossref
Crossref
Sean Lim, Wentao Li, Jessica Kemper, Andrew Nguyen, Ben Willem Mol & Maya Reddy. (2021) Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia. Obstetrics & Gynecology 137:1, pages 72-81.
Crossref
Crossref
Kate Wiles, Lucy C. Chappell, Liz Lightstone & Kate Bramham. (2020) Updates in Diagnosis and Management of Preeclampsia in Women with CKD. Clinical Journal of the American Society of Nephrology 15:9, pages 1371-1380.
Crossref
Crossref
Adi L. Tarca, Roberto Romero, Neta Benshalom-Tirosh, Nandor Gabor Than, Dereje W. Gudicha, Bogdan Done, Percy Pacora, Tinnakorn Chaiworapongsa, Bogdan Panaitescu, Dan Tirosh, Nardhy Gomez-Lopez, Sorin Draghici, Sonia S. Hassan & Offer Erez. (2019) The prediction of early preeclampsia: Results from a longitudinal proteomics study. PLOS ONE 14:6, pages e0217273.
Crossref
Crossref
Elizabeth A. Phipps, Ravi Thadhani, Thomas Benzing & S. Ananth Karumanchi. (2019) Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nature Reviews Nephrology 15:5, pages 275-289.
Crossref
Crossref
Michael C. Honigberg, Ellen W. Seely, Ann M. Thomas, Kee-Hak Lim, Samuel Parry & Thomas F. McElrath. (2018) Infant size and the association between maternal circulating angiogenic factors and preeclampsia. Journal of Perinatology 38:5, pages 456-461.
Crossref
Crossref
K. Camacho-Méndez, E. Ventura-Arizmendi, A. Zárate & M. Hernández-Valencia. (2018) Utilidad de los biomarcadores séricos involucrados en la fisiopatología de la preeclampsia como predictores tempranos de diagnóstico. Perinatología y Reproducción Humana 32:1, pages 39-42.
Crossref
Crossref
Kathryn J. Gray, Richa Saxena & S. Ananth Karumanchi. (2018) Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis. American Journal of Obstetrics and Gynecology 218:2, pages 211-218.
Crossref
Crossref
S. Ananth Karumanchi. 2018. Textbook of Nephro-Endocrinology. Textbook of Nephro-Endocrinology
319
345
.
Elizabeth V. Schulz, Lori Cruze, Wei Wei, John Gehris & Carol L. Wagner. (2017) Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy. The Journal of Steroid Biochemistry and Molecular Biology 173, pages 273-279.
Crossref
Crossref
Sarosh Rana & S. Ananth Karumanchi. 2017. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology
1724
1732.e2
.
S.A. Karumanchi. 2017. Biomarkers of Kidney Disease. Biomarkers of Kidney Disease
555
594
.
Pitchaphon Nissaisorakarn, Sairah Sharif & Belinda Jim. (2016) Hypertension in Pregnancy: Defining Blood Pressure Goals and the Value of Biomarkers for Preeclampsia. Current Cardiology Reports 18:12.
Crossref
Crossref
Geoff K Frampton, Jeremy Jones, Micah Rose & Liz Payne. (2016) Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment 20:87, pages 1-160.
Crossref
Crossref
Suzy Duckworth, Melanie Griffin, Paul T. Seed, Robyn North, Jenny Myers, Lucy Mackillop, Nigel Simpson, Jason Waugh, Dilly Anumba, Louise C. Kenny, Christopher W. G. Redman, Andrew H. Shennan & Lucy C. Chappell. (2016) Diagnostic Biomarkers in Women With Suspected Preeclampsia in a Prospective Multicenter Study. Obstetrics & Gynecology 128:2, pages 245-252.
Crossref
Crossref
Kedak Baltajian, Surichhya Bajracharya, Saira Salahuddin, Anders H. Berg, Carl Geahchan, Julia B. Wenger, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2016) Sequential plasma angiogenic factors levels in women with suspected preeclampsia. American Journal of Obstetrics and Gynecology 215:1, pages 89.e1-89.e10.
Crossref
Crossref
S. Ananth Karumanchi. (2016) Angiogenic Factors in Preeclampsia. Hypertension 67:6, pages 1072-1079.
Crossref
Crossref
Steven J. Korzeniewski, Roberto Romero, Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Chong Jai Kim, Yeon Mee Kim, Jung-Sun Kim, Bo Hyun Yoon, Sonia S. Hassan & Lami Yeo. (2016) Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. American Journal of Obstetrics and Gynecology 214:5, pages 629.e1-629.e17.
Crossref
Crossref
Langeza Saleh, Koen Verdonk, A.H. Jan Danser, Eric A.P. Steegers, Henk Russcher, Anton H. van den Meiracker & Willy Visser. (2016) The sFlt-1/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort. European Journal of Obstetrics & Gynecology and Reproductive Biology 199, pages 121-126.
Crossref
Crossref
Harald Zeisler, Elisa Llurba, Frederic Chantraine, Manu Vatish, Anne Cathrine Staff, Maria Sennström, Matts Olovsson, Shaun P. Brennecke, Holger Stepan, Deirdre Allegranza, Peter Dilba, Maria Schoedl, Martin Hund & Stefan Verlohren. (2016) Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. New England Journal of Medicine 374:1, pages 13-22.
Crossref
Crossref
Ellen W. Seely & Caren G. Solomon. (2016) Improving the Prediction of Preeclampsia. New England Journal of Medicine 374:1, pages 83-84.
Crossref
Crossref
Lene G. Rasmussen, Jacob A. Lykke & Anne C. Staff. (2015) Angiogenic biomarkers in pregnancy: defining maternal and fetal health. Acta Obstetricia et Gynecologica Scandinavica 94:8, pages 820-832.
Crossref
Crossref
Melissa I. March, Carl Geahchan, Julia Wenger, Nandini Raghuraman, Anders Berg, Hamish Haddow, Bri Ann Mckeon, Rulx Narcisse, Jean Louis David, Jennifer Scott, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2015) Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia. PLOS ONE 10:5, pages e0126815.
Crossref
Crossref
Gabor Szalai, Roberto Romero, Tinnakorn Chaiworapongsa, Yi Xu, Bing Wang, Hyunyoung Ahn, Zhonghui Xu, Po Jen Chiang, Birgitta Sundell, Rona Wang, Yang Jiang, Olesya Plazyo, Mary Olive, Adi L. Tarca, Zhong Dong, Faisal Qureshi, Zoltan Papp, Sonia S. Hassan, Edgar Hernandez-Andrade & Nandor Gabor Than. (2015) Full-Length Human Placental sFlt-1-e15a Isoform Induces Distinct Maternal Phenotypes of Preeclampsia in Mice. PLOS ONE 10:4, pages e0119547.
Crossref
Crossref
Glenn E. Palomaki, James E. Haddow, Hamish R. M. Haddow, Saira Salahuddin, Carl Geahchan, Ana Sofia Cerdeira, Stefan Verlohren, Frank H. Perschel, Gary Horowitz, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2015) Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenatal Diagnosis 35:4, pages 386-393.
Crossref
Crossref
Monica Sircar, Ravi Thadhani & S. Ananth Karumanchi. (2015) Pathogenesis of preeclampsia. Current Opinion in Nephrology and Hypertension 24:2, pages 131-138.
Crossref
Crossref
Pauline Mendola, Sunni L. Mumford, Tuija I. Männistö, Alexander Holston, Uma M. Reddy & S. Katherine Laughon. (2015) Controlled Direct Effects of Preeclampsia on Neonatal Health After Accounting for Mediation by Preterm Birth. Epidemiology 26:1, pages 17-26.
Crossref
Crossref
Gabor Szalai, Yi Xu, Roberto Romero, Tinnakorn Chaiworapongsa, Zhonghui Xu, Po Jen Chiang, Hyunyoung Ahn, Birgitta Sundell, Olesya Plazyo, Yang Jiang, Mary Olive, Bing Wang, Suzanne M. Jacques, Faisal Qureshi, Adi L. Tarca, Offer Erez, Zhong Dong, Zoltan Papp, Sonia S. Hassan, Edgar Hernandez-Andrade & Nandor Gabor Than. (2014) In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy. PLoS ONE 9:11, pages e110867.
Crossref
Crossref
Nandini Raghuraman, Melissa I. March, Michele R. Hacker, Anna Merport Modest, Julia Wenger, Rulx Narcisse, Jean Louis David, Jennifer Scott & Sarosh Rana. (2014) Adverse maternal and fetal outcomes and deaths related to preeclampsia and eclampsia in Haiti. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 4:4, pages 279-286.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Steven J. Korzeniewski, Lami Yeo & Roberto Romero. (2014) Pre-eclampsia part 2: prediction, prevention and management. Nature Reviews Nephrology 10:9, pages 531-540.
Crossref
Crossref
Sarosh RanaS. Ananth KarumanchiMarshall D. Lindheimer. (2014) Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia. Hypertension 63:2, pages 198-202.
Crossref
Crossref
Silvia Martina Lobmaier, Francesc Figueras, Imma Mercade, Francesca Crovetto, Anna Peguero, Miguel Parra-Saavedra, Javier U. Ortiz, Fatima Crispi & Eduard Gratacós. (2014) Levels of Maternal Serum Angiogenic Factors in Third-Trimester Normal Pregnancies: Reference Ranges, Influence of Maternal and Pregnancy Factors and Fetoplacental Doppler Indices. Fetal Diagnosis and Therapy 36:1, pages 38-43.
Crossref
Crossref
Lucy C. ChappellSuzy DuckworthPaul T. SeedMelanie GriffinJenny MyersLucy MackillopNigel SimpsonJason WaughDilly AnumbaLouise C. KennyChristopher W.G. RedmanAndrew H. Shennan. (2013) Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia. Circulation 128:19, pages 2121-2131.
Crossref
Crossref
Arvind Goel & Sarosh Rana. (2013) Angiogenic factors in preeclampsia. Current Opinion in Nephrology & Hypertension 22:6, pages 643-650.
Crossref
Crossref
WT Schnettler, D Dukhovny, J Wenger, S Salahuddin, SJ Ralston & S Rana. (2013) Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology 120:10, pages 1224-1232.
Crossref
Crossref
Anne Cathrine StaffSamantha J. BentonPeter von DadelszenJames M. RobertsRobert N. TaylorRobert W. PowersD. Stephen Charnock-JonesChristopher W.G. Redman. (2013) Redefining Preeclampsia Using Placenta-Derived Biomarkers. Hypertension 61:5, pages 932-942.
Crossref
Crossref
Mihran V. Naljayan & S. Ananth Karumanchi. (2013) New Developments in the Pathogenesis of Preeclampsia. Advances in Chronic Kidney Disease 20:3, pages 265-270.
Crossref
Crossref
Tatsuo Yamamoto, Fumihisa Chishima & Masahiko Matsuura. (2013) Prediction of preeclampsia using angiogenic and antiangiogenic factors. Hypertension Research in Pregnancy 1:2, pages 66-70.
Crossref
Crossref